1. Guest, the 'News in Brief' for the week beginning 27th June 2022 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Erythrocytes Induce Vascular Dysfunction in COVID-19, 2022, Mahdi et al

Discussion in 'Epidemics (including Covid-19, not Long Covid)' started by Andy, Feb 24, 2022.

  1. Andy

    Andy Committee Member

    Hampshire, UK

    • Patients hospitalized for COVID-19 display marked impairment in endothelial function, which is persistent following recovery from the acute infection.
    • Red blood cells (RBCs) from patients with COVID-19 impair vascular function through mechanisms involving increased arginase 1, reactive oxygen species (ROS) and interferon γ (IFNγ), and reduced nitric oxide (NO) bioactivity.
    • These data advance our understanding in COVID-19–associated vascular injury with a clear involvement of RBCs.
    • Targeting these mechanisms might provide a novel therapeutic strategy to alleviate vascular injury in patients with COVID-19.


    Current knowledge regarding mechanisms underlying cardiovascular complications in patients with COVID-19 is limited and urgently needed. We shed light on a previously unrecognized mechanism and unravel a key role of red blood cells, driving vascular dysfunction in patients with COVID-19 infection. We establish the presence of profound and persistent endothelial dysfunction in vivo in patients with COVID-19. Mechanistically, we show that targeting reactive oxygen species or arginase 1 improves vascular dysfunction mediated by red blood cells. These translational observations hold promise that restoring the redox balance in red blood cells might alleviate the clinical complications of COVID-19–associated vascular dysfunction.

    Open access, https://www.sciencedirect.com/science/article/pii/S2452302X2100396X
    alktipping, Lilas, Yvonne and 8 others like this.

Share This Page